. . . . . . . . . "evomela is an alkylating drug indicated for 1 1 1 2 evomela is indicated for use as a high dose conditioning treatment prior to hematopoietic progenitor stem cell transplantation in patients with multiple myeloma evomela is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "TmwKqt2vFrRJL/3jWboMtIJo7GONFuQaL08lfT/7L2gwZS7E2HufMEq+uot/xSetAVeHQmHUkfx2Az/pbs+FbocKgCzxSABLLO8vQRYTBfKGzHh1VyXLWrMHIe9BM8/ggFreH+uCiWCsmHmUxj6T8SGIOrATKkFeaaBvzPT/GkA=" . . "2021-06-29T08:30:42.451+02:00"^^ . . . . .